ArticleActa pharmaceutica Sinica. B2021

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses.

Yilan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.